ArticleIJID regions2026
Strengthening regional surveillance: MenMap Network's year 1 findings on bacterial meningitis in Jordan, Egypt, and Iraq (2023-2024).
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Vaccine-preventable invasive bacterial diseases remain a public health concern in the Middle East and North Africa (MENA) region. To address surveillance and diagnostic gaps, the Meningitis and Septicemia Mapping Network (MenMap) was launched as a prospective, multicenter sentinel surveillance system to strengthen laboratory capacity and regional collaboration in Jordan, Egypt, and Iraq. This study reports the first-year MenMap findings (December 2023 to November 2024), describing bacterial meningitis epidemiology, pathogen distribution, vaccination status, clinical presentation, and outcomes among laboratory-confirmed cases in Jordan, Egypt, and Iraq. Methods: Prospective sentinel hospital-based surveillance was implemented in 16 hospitals, targeting children aged 1 month to 18 years. Suspected cases were defined according to World Health Organization criteria and included patients presenting with clinical signs of meningitis and undergoing cerebrospinal fluid and/or blood sampling. Standardized protocols included clinical evaluations, real-time polymerase chain reaction for pathogen detection, and continuous monitoring systems. An external quality assessment scheme ensured laboratory diagnostic quality and accuracy. Results: Between December 2023 and November 2024, 2104 suspected cases were reported, with 191 (9%) confirmed Conclusion: MenMap strengthens bacterial meningitis surveillance in the MENA region and provides critical evidence to support vaccine policy decisions, including expansion of pneumococcal and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.